Vnitr Lek 2006, 52(4):306-307

Je kardiotoxicita chemoterapie problémem onkologa nebo také kardiologa? - editorial

R. Pudil*, J. M. Horáček
I. interní klinika Lékařské fakulty UK a FN, Hradec Králové, přednosta prof. MUDr. Jan Vojáček, DrSc., FESC

Received: February 20, 2006; Published: April 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudil R, Horáček JM. Je kardiotoxicita chemoterapie problémem onkologa nebo také kardiologa? - editorial. Vnitr Lek. 2006;52(4):306-307.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Yeh E, Tong A, Lenihan D et al. Cardiovascular Complications of Cancer Therapy. Diagnosis, Pathogenesis, and Management. Circulation 2004; 109: 3122-3131. Go to original source... Go to PubMed...
    2. Elbl L. Srdce a hematologická a onkologická onemocnění. In: Aschermann M et al. Kardiologie. Praha: Galén 2004: 1389-1398.
    3. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003; 97: 2869-2879. Go to original source... Go to PubMed...
    4. Pudil R, Hrncir Z. Severe bradycardia after a methylprednisolone "minipulse" treatment. Arch Intern Med 2001; 161: 1778-1779. Go to original source... Go to PubMed...
    5. Ewer S, Lippman SM. Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity. J Clin Oncol 2005; 23: 2900-2902. Go to original source... Go to PubMed...
    6. Horacek JM, Pudil R, Tichy M et al. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. Neoplasma 2005; 52: 430-434. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.